Immune-mediated diseases impact 1:7 people and are increasing in prevalence worldwide. They occur when the immune system mistakenly attacks the tissues of the body and can result in permanent organ damage or even death. Despite advances in treatment, many patients with immune-mediated diseases suffer from poor outcomes when their disease cannot be controlled with available therapies. At Climb Bio, we believe that we can impact the pathways that cause immune-mediated diseases to give patients precious time free of disease.

Biotechnology

Health Care

Life Sciences

Therapeutics

Climb Bio

The Wellesley office likely focuses on strategic business management and program development, supporting executive leadership.

Wellesley

Aoife Brennan

Kate Hecht

Chandra Adams

Theresa Donegan

Satej Bhandarkar

Ashley Jones

Susan Altschuller

Perrin Wilson

Adam Villa

Edgar D. Charles

This department oversees project planning and execution, ensuring successful delivery of programs and initiatives.

Program Management

This department focuses on overseeing clinical operations and ensuring quality standards are met in regulatory affairs.

Clinical Operations and Quality

This department manages financial transactions, ensures accurate reporting, and oversees budget compliance.

Accounting Department

This department oversees the organization's strategic direction and ensures effective governance through the board of directors.

Board Governance

This department manages the planning, execution, and oversight of clinical trials to ensure compliance with regulatory standards.

Clinical Operations

This department manages financial planning, reporting, and accounting functions.

Climb Bio

Org chart

Teams

Program Management

Clinical Operations and Quality

Accounting Department

Board Governance

Clinical Operations

Finance Department

Offices